Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ferula assa-foetida on egg quantity and quality in infertile women with polycystic ovary syndrome
IRCT20241127063875N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ferula assa-foetida in polycystic ovary syndrome (PCOS) and female infertility, sponsored by Tehran University of Medical Sciences. Primary endpoints: Change in egg quantity and Change in egg quality. Started Feb 2025; status: completed.
02
Drugs
ferula assa-foetida
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20241127063875N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241127063875N1.